Finance

Lists
301093:SHE
Jiangsu Hualan New Pharmctcl Mtrl Co Ltd
CN¥63.11
0.00%
(0.00) 1D
Sep 30, 3:04:07 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301093...
Open
CN¥63.77
High
CN¥66.20
Low
CN¥62.34
Mkt. cap
13.45B
Avg. vol.
6.32M
Volume
0.00
Dividend
0.06%
Quarterly dividend
CN¥0.01
Ex-dividend date
Jul 16, 2026
P/E ratio
557.31
52-wk high
CN¥110.32
52-wk low
CN¥26.08
EPS
CN¥0.11
Shares outstanding
213.13M
No. of employees
945
Open
CN¥63.77
High
CN¥66.20
Low
CN¥62.34
Mkt. cap
13.45B
Avg. vol.
6.32M
Volume
0.00
Dividend
0.06%
Quarterly dividend
CN¥0.01
Ex-dividend date
Jul 16, 2026
P/E ratio
557.31
52-wk high
CN¥110.32
52-wk low
CN¥26.08
EPS
CN¥0.11
Shares outstanding
213.13M
No. of employees
945
News stories
From web sources and news partners
About Jiangsu Hualan New Pharmctcl Mtrl Co Ltd
CEO-
Employees945
FoundedJun 4, 1992
Headquarters-
SectorMedical device
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
132.48M
178.21M
129.56M
168.48M
Cost of goods sold
80.54M
112.49M
81.34M
101.28M
Cost of revenue
80.54M
112.49M
81.34M
101.28M
Research and development expenses
11.49M
9.97M
11.08M
11.84M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
30.51M
48.82M
40.49M
48.00M
Operating expense
38.98M
64.63M
51.53M
64.52M
Total operating expenses
119.52M
177.12M
132.87M
165.80M
Operating income
12.96M
1.08M
-3.31M
2.68M
Other non operating income
1.15M
-1.45M
-1.52M
1.25M
EBT including unusual items
11.86M
7.13M
362.74K
6.42M
EBT excluding unusual items
12.90M
3.28M
-3.35M
4.99M
Income tax expense
2.36M
490.19K
58.06K
-441.76K
Effective tax rate
19.90%
6.88%
16.00%
-6.88%
Other operating expenses
-2.09M
4.83M
58.66K
2.44M
Net income
9.58M
6.86M
609.65K
7.06M
Net profit margin
7.23%
3.85%
0.47%
4.19%
Earnings per share
-
-
-
-
Interest and investment income
2.18M
2.40M
1.87M
4.45M
Interest expense
-490.32K
-629.48K
-385.97K
-497.32K
Net interest expenses
1.69M
1.77M
1.48M
3.95M
Depreciation and amortization charges
-
-
-
-
EBITDA
26.80M
17.70M
13.30M
22.30M
Gain or loss from assets sale
-616.30K
541.22K
-
169.35K
AI content may include mistakes. Learn more
Google apps